New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids

Qinghaosu Antimalarial Coordinating Research Group, 1979, Antimalaria studies on Qinghaosu, Chin. Med. J. (Engl.), 12, 811 Li, 2003, An over four millennium story behind Qinghaosu (artemisinin): a fantastic antimalarial drug from a traditional Chinese herb, Curr. Med. Chem., 10, 2197, 10.2174/0929867033456710 Miller, 2011, Artemisinin: discovery from the Chinese herbal Garden, Cell, 146, 855, 10.1016/j.cell.2011.08.024 Klayman, 1985, Qinghaosu (artemisinin): an antimalarial drug from China, Science, 228, 1049, 10.1126/science.3887571 Olliaro, 2003, Antimalarial compounds: from bench to bedside, J. Exp. Biol., 206, 3753, 10.1242/jeb.00653 Jung, 2004, Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents, Curr. Med. Chem., 11, 1265, 10.2174/0929867043365233 Meunier, 2010, Heme as trigger and target for trioxane-containing antimalarial drugs, Acc. Chem. Res., 43, 1444, 10.1021/ar100070k Chaturvedi, 2010, Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents, Chem. Soc. Rev., 39, 435, 10.1039/B816679J Wu, 2011, Road towards new antimalarials – overview of the strategies and their chemical progress, Curr. Med. Chem., 18, 853, 10.2174/092986711794927748 Kumar, 2011, Medicinal chemistry perspectives of trioxanes and tetraoxanes, Curr. Med. Chem., 18, 3889, 10.2174/092986711803414340 Slack, 2012, Antimalarial peroxides: advances in drug discovery and design, Med. Chem. Commun., 3, 281, 10.1039/c2md00277a Woerdenbag, 1993, Cytotoxicity of artemisinin-related endoperoxides to ehrlich ascites tumor cells, J. Nat. Prod., 56, 849, 10.1021/np50096a007 Efferth, 1996, Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs, Arzneimittelforschung, 46, 196 Beekman, 1997, Stereochemistry-dependent cytotoxicity of some artemisinin derivatives, J. Nat. Prod., 60, 325, 10.1021/np9605495 Chen, 2003, Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro, Pharmacol. Res., 48, 231, 10.1016/S1043-6618(03)00107-5 Singh, 2004, Artemisinin induces apoptosis in human cancer cells, Anticancer Res., 24, 2277 Yamachika, 2004, Artemisinin: an alternative treatment for oral squamous cell carcinoma, Anticancer Res., 24, 2153 Chen, 2004, Antimalarial dihydroartemisinin also inhibits angiogenesis, Cancer Chemother. Pharmacol., 53, 423, 10.1007/s00280-003-0751-4 Efferth, 2004, Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron, Free Radic. Biol. Med., 37, 998, 10.1016/j.freeradbiomed.2004.06.023 Efferth, 2005, Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy, Drug Resist. Updat., 8, 85, 10.1016/j.drup.2005.04.003 Efferth, 2007, Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside, Planta Med., 73, 299, 10.1055/s-2007-967138 Cabello, 2012, The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis, Invest. New Drugs, 30, 1289, 10.1007/s10637-011-9676-7 Crespo-Ortiz, 2012, Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug, J. Biomed. Biotechnol., 2012, 247597 Lai, 2013, Development of artemisinin compounds for cancer treatment, Invest. New Drugs, 31, 230, 10.1007/s10637-012-9873-z Qian, 1982, The immunologic and antiviral effect of qinghaosu, J. Tradit. Chin. Med., 2, 271 Romero, 2005, Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system, Antivir. Res., 68, 75, 10.1016/j.antiviral.2005.07.005 Paeshuyse, 2006, Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin, Biochem. Biophys. Res. Commun., 348, 139, 10.1016/j.bbrc.2006.07.014 Romero, 2006, Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV), Planta Med., 72, 1169, 10.1055/s-2006-947198 Efferth, 2008, The antiviral activities of artemisinin and artesunate, Clin. Infect. Dis., 47, 804, 10.1086/591195 Wohlfarth, 2009, Natural products as promising drug candidates for the treatment of hepatitis B and C, Acta Pharmacol. Sin., 30, 25, 10.1038/aps.2008.5 Meshnick, 1996, Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy, Microbiol. Rev., 60, 301, 10.1128/MMBR.60.2.301-315.1996 Cumming, 1997, Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action, Adv. Pharmacol., 37, 253, 10.1016/S1054-3589(08)60952-7 Efferth, 2004, Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines, Biochem. Pharmacol., 68, 3, 10.1016/j.bcp.2004.03.003 Wondrak, 2009, Redox-directed cancer therapeutics: molecular mechanisms and opportunities, Antioxid. Redox Signal, 11, 3013, 10.1089/ars.2009.2541 O'Neill, 2010, The molecular mechanism of action of artemisinin – the debate continues, Molecules, 15, 1705, 10.3390/molecules15031705 Eichhorn, 2012, Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells, Mol. Biosyst., 8, 1311, 10.1039/c2mb05437j Eichhorn, 2013, Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum, Biochem. Pharmacol., 85, 38, 10.1016/j.bcp.2012.10.006 Obeid, 2013, Artemisinin analogues as potent inhibitors of in Vitro Hepatitis C Virus replication, PLoS One, 8, e81783, 10.1371/journal.pone.0081783 Noedl, 2008, Evidence of artemisinin-resistant malaria in Western Cambodia, N. Engl. J. Med., 359, 2619, 10.1056/NEJMc0805011 Dondorp, 2009, Artemisinin resistance in Plasmodium falciparum malaria, N. Engl. J. Med., 361, 455, 10.1056/NEJMoa0808859 Amaratunga, 2012, Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study, Lancet Infect. Dis., 12, 851, 10.1016/S1473-3099(12)70181-0 Pyae Phyo, 2012, Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study, Lancet, 379, 1960, 10.1016/S0140-6736(12)60484-X Mehta, 2002, Hybrid systems through natural product leads: an approach towards new molecular entities, Chem. Soc. Rev., 31, 324, 10.1039/b204748a Tietze, 2003, Natural product hybrids as new leads for drug discovery, Angew. Chem. Int. Ed., 42, 3996, 10.1002/anie.200200553 Ganesan, 2004, Natural products as a hunting ground for combinatorial chemistry, Curr. Opin. Biotechnol., 15, 584, 10.1016/j.copbio.2004.09.002 Gademann, 2006, Natural product hybrids, Chimia, 60, 841, 10.2533/chimia.2006.841 Meunier, 2008, Hybrid molecules with a dual mode of action: dream or reality?, Acc. Chem. Res., 41, 69, 10.1021/ar7000843 Tsogoeva, 2010, Recent progress in the development of synthetic hybrids of natural or unnatural bioactive compounds for medicinal chemistry, Mini Rev. Med. Chem., 10, 773, 10.2174/138955710791608280 Stocks, 2007, Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs, Angew. Chem. Int. Ed., 46, 6278, 10.1002/anie.200604697 Chadwick, 2009, Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells, Bioorg. Med. Chem., 17, 1325, 10.1016/j.bmc.2008.12.017 Horwedel, 2010, Cytotoxicity of artesunic acid Homo- and Heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells, J. Med. Chem., 53, 4842, 10.1021/jm100404t Lombard, 2010, Artemisinin-quinoline hybrid-dimers: synthesis and in vitro antiplasmodial activity, Bioorg. Med. Chem. Lett., 20, 6975, 10.1016/j.bmcl.2010.09.130 Xie, 2011, Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach, Chem. Pharm. Bull., 59, 984, 10.1248/cpb.59.984 Ricci, 2011, Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents, Chem. Pharm. Bull., 59, 1471, 10.1248/cpb.59.1471 He, 2011, An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities, PLoS One, 6, e24334, 10.1371/journal.pone.0024334 He, 2012, artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication, Antimicrob. Agents Chemother., 56, 3508, 10.1128/AAC.00519-12 Reiter, 2012, New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells, Bioorg. Med. Chem., 20, 5637, 10.1016/j.bmc.2012.07.015 Biot, 1997, Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue, J. Med. Chem., 40, 3715, 10.1021/jm970401y Biot, 2011, The antimalarial Ferroquine: from bench to clinic, Parasite, 18, 207, 10.1051/parasite/2011183207 Roux, 2012, Ferrocene-based antimalarials, Future Med. Chem., 4, 783, 10.4155/fmc.12.26 Dubar, 2013, The Ferroquine antimalarial conundrum: redox activation and reinvasion inhibition, Angew. Chem. Int. Ed., 52, 7690, 10.1002/anie.201303690 Top, 1997, Facile route to ferrocifen, 1-[4-(2-dimethylaminoethoxy)]-1-(phenyl-2-ferrocenyl-but-1-ene), first organometallic analogue of tamoxifen, by the McMurry reaction, J. Organomet. Chem., 541, 355, 10.1016/S0022-328X(97)00086-7 Top, 2001, Studies on organometallic selective estrogen receptor modulators. (SERMs) dual activity in the hydroxy-ferrocifen series, J. Organomet. Chem., 637, 500, 10.1016/S0022-328X(01)00953-6 Jaouen, 2004, The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer, Curr. Med. Chem., 11, 2505, 10.2174/0929867043364487 Hillard, 2006, Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast cancer drug candidates, Angew. Chem. Int. Ed., 45, 285, 10.1002/anie.200502925 Nguyen, 2007, Ferrocifens and ferrocifenols as new potential weapons against breast cancer, Chimia, 61, 716, 10.2533/chimia.2007.716 Michard, 2008, Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines, J. Inorg. Biochem., 102, 1980, 10.1016/j.jinorgbio.2008.07.014 Nguyen, 2014, Organometallic nucleoside analogues with ferrocenyl linker groups: synthesis and cancer cell line studies, J. Med. Chem., 57, 5817, 10.1021/jm500246h Delhaes, 2000, Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX, Bioorg. Med. Chem., 8, 2739, 10.1016/S0968-0896(00)00206-6 Bellot, 2010, Trioxaferroquines as new hybrid antimalarial drugs, J. Med. Chem., 53, 4103, 10.1021/jm100117e Reiter, 2014, Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells, Eur. J. Med. Chem., 75, 403, 10.1016/j.ejmech.2014.01.043 Jung, 1991, A concise synthesis of 12-(3'-hydroxy-n-propyl)-deoxoartemisinin, Bioorg. Med. Chem. Lett., 1, 741, 10.1016/S0960-894X(01)81060-X Haynes, 1992, Efficient preparation of novel qinghaosu (Artemisinin) derivatives: conversion of qinghao (Artemisinic) acid into deoxoqinghaosu derivatives and 5-Carba-4-deoxoartesunic acid, Synlett, 481, 10.1055/s-1992-21384 Pu, 1993, An unusual acid-catalyzed rearrangement of 1,2,4-trioxanes, Heterocycles, 36, 2099, 10.3987/COM-93-6430 Pu, 1995, Synthesis and antimalarial activities of 12beta-allyldeoxoartemisinin and its derivatives, J. Med. Chem., 38, 613, 10.1021/jm00004a007 O'Neill, 2001, Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin: synthesis and in vitro antimalarial activity of new, metabolically stable C-10 analogues, J. Chem. Soc. Perkin Trans. I, 2682, 10.1039/b104340b Woodard, 2009, Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose, J. Med. Chem., 52, 7458, 10.1021/jm9005934 Posner, 2003, Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy, J. Med. Chem., 46, 1060, 10.1021/jm020461q Posner, 2004, Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents, J. Med. Chem., 47, 1299, 10.1021/jm0303711 Alagbala, 2006, Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines, J. Med. Chem., 49, 7836, 10.1021/jm060803i Jung, 2006, Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane, Bioorg. Med. Chem. Lett., 16, 1227, 10.1016/j.bmcl.2005.11.074 Posner, 2007, Malaria-infected mice are cured by a single dose of novel artemisinin derivatives, J. Med. Chem., 50, 2516, 10.1021/jm070149m Posner, 2008, Malaria-infected mice are cured by oral administration of new artemisinin derivatives, J. Med. Chem., 51, 1035, 10.1021/jm701168h Rosenthal, 2009, Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also Selectively and Powerfully cytotoxic to cancer cells, J. Med. Chem., 52, 1198, 10.1021/jm801484v Ricci, 2010, Concise synthesis and antiangiogenic activity of artemisinin–glycolipid hybrids on chorioallantoic membranes, Bioorg. Med. Chem. Lett., 20, 6858, 10.1016/j.bmcl.2010.08.013 Jeyadevan, 2004, Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin, J. Med. Chem., 47, 1290, 10.1021/jm030974c CCDC-994084 and CCDC-994085 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. Saab, 2012, Phytochemical analysis and cytotoxicity towards multidrug-resistant leukemia cells of essential oils derived from Lebanese medicinal plants, Planta Med., 78, 1927, 10.1055/s-0032-1327896 Marschall, 2000, Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents, Antimicrob. Agents Chemother., 44, 1588, 10.1128/AAC.44.6.1588-1597.2000 Marschall, 2012, In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses, Antimicrob. Agents Chemother., 56, 1135, 10.1128/AAC.05908-11 Kaptein, 2006, The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo, Antivir. Res., 69, 60, 10.1016/j.antiviral.2005.10.003 Chou, 2011, The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants, Antivir. Res., 92, 364, 10.1016/j.antiviral.2011.07.018 Kimmig, 1990, Susceptibility of multidrug-resistant human leukemia cell lines to human Interleukin 2-activated Killer cells, Cancer Res., 50, 6793 Gillet, 2004, Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes, Cancer Res., 64, 8987, 10.1158/0008-5472.CAN-04-1978 Efferth, 2008, Prediction of Broad spectrum resistance of Tumors towards anticancer drugs, Clin. Cancer Res., 14, 2405, 10.1158/1078-0432.CCR-07-4525 O'Brien, 2000, Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, Eur. J. Biochem., 267, 5421, 10.1046/j.1432-1327.2000.01606.x Kuete, 2012, Antibacterial activity and cytotoxicity of selected Egyptian medicinal plants, Planta Med., 78, 193, 10.1055/s-0031-1280319 Lambros, 1979, Synchronization of Plasmodium falciparum erythrocytic stages in culture, J. Parasitol., 65, 418, 10.2307/3280287 Smilkstein, 2004, Simple and inexpensive fluorescence-based technique for highthroughput antimalarial drug screening, Antimicrob. Agents Chemother., 48, 1803, 10.1128/AAC.48.5.1803-1806.2004 Beez, 2011, Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites, Antimicrob. Agents Chemother., 55, 50, 10.1128/AAC.00916-10